Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PXL01 versus placebo in flexor tendon surgery
2009-012703-25Phase 2Completed
- Sponsor
- Pergamum AB
- Start
- Sep 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Flexor tendon injury of the finger and tendon rupture comparing PXL01 in sodium hyaluronate with Placebo (2 arms). Primary endpoint: Total Active Motion at PIP and DIP joints at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
ensereptide
03
Conditions
Flexor tendon injury of the fingertendon rupture
Beyond the preview
Go deeper on 2009-012703-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012703-25.